Laboratorio Reig Jofre, S.A.

BME:RJF Voorraadrapport

Marktkapitalisatie: €233.0m

Laboratorio Reig Jofre Toekomstige groei

Future criteriumcontroles 4/6

Laboratorio Reig Jofre is forecast to grow earnings and revenue by 25.2% and 8.7% per annum respectively. EPS is expected to grow by 24% per annum. Return on equity is forecast to be 7% in 3 years.

Belangrijke informatie

25.2%

Groei van de winst

24.0%

Groei van de winst per aandeel

Pharmaceuticals winstgroei15.4%
Inkomstengroei8.7%
Toekomstig rendement op eigen vermogen7.0%
Dekking van analisten

Low

Laatst bijgewerkt31 Oct 2024

Recente toekomstige groei-updates

Recent updates

Calculating The Fair Value Of Laboratorio Reig Jofre, S.A. (BME:RJF)

Jun 22
Calculating The Fair Value Of Laboratorio Reig Jofre, S.A. (BME:RJF)

These 4 Measures Indicate That Laboratorio Reig Jofre (BME:RJF) Is Using Debt Extensively

Feb 02
These 4 Measures Indicate That Laboratorio Reig Jofre (BME:RJF) Is Using Debt Extensively

This Analyst Just Downgraded Their Laboratorio Reig Jofre, S.A. (BME:RJF) EPS Forecasts

Mar 07
This Analyst Just Downgraded Their Laboratorio Reig Jofre, S.A. (BME:RJF) EPS Forecasts

We Think Laboratorio Reig Jofre (BME:RJF) Is Taking Some Risk With Its Debt

Mar 07
We Think Laboratorio Reig Jofre (BME:RJF) Is Taking Some Risk With Its Debt

Laboratorio Reig Jofre (BME:RJF) Seems To Use Debt Quite Sensibly

May 17
Laboratorio Reig Jofre (BME:RJF) Seems To Use Debt Quite Sensibly

The Laboratorio Reig Jofre (BME:RJF) Share Price Has Gained 146%, So Why Not Pay It Some Attention?

Mar 07
The Laboratorio Reig Jofre (BME:RJF) Share Price Has Gained 146%, So Why Not Pay It Some Attention?

Is Laboratorio Reig Jofre (BME:RJF) Using Too Much Debt?

Jan 14
Is Laboratorio Reig Jofre (BME:RJF) Using Too Much Debt?

Laboratorio Reig Jofre (BME:RJF) Shareholders Booked A 47% Gain In The Last Year

Dec 05
Laboratorio Reig Jofre (BME:RJF) Shareholders Booked A 47% Gain In The Last Year

Winst- en omzetgroeiprognoses

BME:RJF - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/2026408179N/A1
12/31/2025379155N/A1
12/31/2024349112N/A1
9/30/202433410N/AN/AN/A
6/30/20243349-316N/A
3/31/20243269N/AN/AN/A
12/31/20233189619N/A
9/30/202331612N/AN/AN/A
6/30/202329810618N/A
3/31/202328610N/AN/AN/A
12/31/20222748516N/A
9/30/20222624N/AN/AN/A
6/30/20222565-65N/A
3/31/20222453N/AN/AN/A
12/31/20212405-514N/A
9/30/20212376N/AN/AN/A
6/30/20212345922N/A
3/31/20212346N/AN/AN/A
12/31/20202346719N/A
9/30/20202298N/AN/AN/A
6/30/20202296-1514N/A
3/31/20202196N/AN/AN/A
12/31/20192065-1912N/A
9/30/20191997N/AN/AN/A
6/30/20191889-1016N/A
3/31/20191889N/AN/AN/A
12/31/20181859-615N/A
9/30/201818510N/AN/AN/A
6/30/20181799N/A14N/A
3/31/20181759N/AN/AN/A
12/31/20171729N/A21N/A
9/30/20171645N/AN/AN/A
6/30/20171647N/A8N/A
3/31/20171648N/AN/AN/A
12/31/20161618N/A-1N/A
9/30/20161605N/AN/AN/A
6/30/20161595N/A8N/A
3/31/20161565N/AN/AN/A
12/31/20151579N/A13N/A
12/31/20141339N/A-13N/A
9/30/20141229N/A12N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: RJF's forecast earnings growth (25.2% per year) is above the savings rate (1.7%).

Winst versus markt: RJF's earnings (25.2% per year) are forecast to grow faster than the Spanish market (8.5% per year).

Hoge groeiwinsten: RJF's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: RJF's revenue (8.7% per year) is forecast to grow faster than the Spanish market (5% per year).

Hoge groei-inkomsten: RJF's revenue (8.7% per year) is forecast to grow slower than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: RJF's Return on Equity is forecast to be low in 3 years time (7%).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y